
Ana Laura Mendoza
Ana Laura Mendoza is a patient diagnosed with rheumatoid arthritis who has been prominently featured in the news due to her desperate struggle to obtain essential medication, specifically Adalimumab, which she has not received since May. Her case highlights the severe shortages of critical drugs in the Instituto de Previsión Social (IPS), forcing patients to seek expensive alternatives or rely on community support.
Power69
Reach12,980
Country presence
Recent news mentions
Ana Laura Mendoza expressed her struggle to afford her arthritis medication, which costs G. 29,500,000.
El “gasto de bolsillo” en la salud: el alto costo de enfermarse en Paraguay - NacionalesABC Color – leading Paraguayan newspaper, est. 1967·
Paraguay· 2026-07-26
Ana Laura Mendoza, a patient diagnosed with rheumatoid arthritis, reported that she has not received her essential medication since May.
IPS sin remedios: asegurados gastan millones por crisis - NacionalesABC Color – leading Paraguayan newspaper, est. 1967·
Paraguay· 2026-07-20
Also mentioned
Isaias Fretes





